Alzamend Neuro Inc.

1.00
-0.02 (-1.96%)
At close: Apr 03, 2025, 3:59 PM

Alzamend Neuro Statistics

Share Statistics

Alzamend Neuro has 6.61M shares outstanding. The number of shares has increased by -16.38% in one year.

Shares Outstanding 6.61M
Shares Change (YoY) -16.38%
Shares Change (QoQ) 21.44%
Owned by Institutions (%) 6.35%
Shares Floating 6.32M
Failed to Deliver (FTD) Shares 52
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 132.92K, so 2.45% of the outstanding shares have been sold short.

Short Interest 132.92K
Short % of Shares Out 2.45%
Short % of Float 2.54%
Short Ratio (days to cover) 1.03

Valuation Ratios

The PE ratio is -2.42 and the forward PE ratio is -0.66. Alzamend Neuro's PEG ratio is 0.07.

PE Ratio -2.42
Forward PE -0.66
PS Ratio 0
Forward PS 0.2
PB Ratio -9.26
P/FCF Ratio -2.86
PEG Ratio 0.07
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Alzamend Neuro.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.14, with a Debt / Equity ratio of -0.12.

Current Ratio 0.14
Quick Ratio 0.14
Debt / Equity -0.12
Debt / EBITDA -0.03
Debt / FCF -0.04
Interest Coverage -983.83

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-2.49M
Employee Count 4
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -88.78% in the last 52 weeks. The beta is -0.19, so Alzamend Neuro's price volatility has been lower than the market average.

Beta -0.19
52-Week Price Change -88.78%
50-Day Moving Average 0.97
200-Day Moving Average 1.89
Relative Strength Index (RSI) 56.05
Average Volume (20 Days) 385.76K

Income Statement

Revenue n/a
Gross Profit -50.74K
Operating Income -9.94M
Net Income -9.95M
EBITDA -9.89M
EBIT -9.94M
Earnings Per Share (EPS) -14.72
Full Income Statement

Balance Sheet

The company has 376.05K in cash and 300.71K in debt, giving a net cash position of 75.33K.

Cash & Cash Equivalents 376.05K
Total Debt 300.71K
Net Cash 75.33K
Retained Earnings -54.02M
Total Assets 4.18M
Working Capital 3.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.27M and capital expenditures -147.24K, giving a free cash flow of -8.42M.

Operating Cash Flow -8.27M
Capital Expenditures -147.24K
Free Cash Flow -8.42M
FCF Per Share -2.49
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ALZN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for ALZN is $20, which is 1880.2% higher than the current price. The consensus rating is "Buy".

Price Target $20
Price Target Difference 1880.2%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Jul 16, 2024. It was a backward split with a ratio of 1:10.

Last Split Date Jul 16, 2024
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -16.2
Piotroski F-Score 2